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ABSTRACT: Heme-copper oxidases (HCOs) are key enzymes in
prokaryotes and eukaryotes for energy production during aerobic
respiration. They catalyze the reduction of the terminal electron
acceptor, oxygen, and utilize the Gibbs free energy to transport protons
across a membrane to generate a proton (ΔpH) and electrochemical
gradient termed proton motive force (PMF), which provides the driving
force for the adenosine triphosphate (ATP) synthesis. Excessive PMF is
known to limit the turnover of HCOs, but the molecular mechanism of
this regulatory feedback remains relatively unexplored. Here we present
a single-enzyme study that reveals that cytochrome bo3 from Escherichia
coli, an HCO closely homologous to Complex IV in human
mitochondria, can enter a rare, long-lifetime leak state during which
proton ﬂow is reversed. The probability of entering the leak state is
increased at higher ΔpH. By rapidly dissipating the PMF, we propose
that this leak state may enable cytochrome bo3, and possibly other HCOs, to maintain a suitable ΔpH under extreme redox
conditions.
■ INTRODUCTION
One of the main roles of oxidative phosphorylation in
mitochondria and bacteria is maintaining a proton-motive
force (PMF) across the inner or plasma membrane, thereby
providing most of the energy for the synthesis of adenosine
triphosphate (ATP) in aerobic environments. The PMF is
formed by transferring or pumping protons across the lipid
membrane, generating a transmembrane electrochemical
potential and transmembrane pH diﬀerence (ΔpH). During
aerobic respiration, electron-transport chains of oxidative
phosphorylation terminate with heme-copper oxygen reduc-
tases (HCOs), in which a heme-copper binuclear center
(BNC) binds and reduces dioxygen to water. The HCO in
mitochondria is a cytochrome c oxidase known as Complex IV.
Complex IV and a bacterial homologue, cytochrome bo3 from
Escherichia coli, belong to the A1 subgroup of Type-A HCOs,
which typically pump one proton per electron, therefore four
protons per dioxygen molecule.1 The reduction of dioxygen is
further coupled to the uptake/release of four charges (protons
and/or electrons), adding up to a total of eight charges
transported across the membrane for each dioxygen that is
reduced. Type-A HCOs possess two conserved proton
channels, known as the K- and D-channel, both leading to
the BNC.2−5 The K-channel facilitates the transportation of
“chemical protons” that react with dioxygen to form water; the
D-channel facilitates both the uptake of “chemical protons” and
the transportation of all the pumped protons.6−9 Both channels
take up protons from the same side of the membrane: the
matrix side in mitochondria or the cytoplasmic side in
bacteria.2,3
Despite various high-resolution structures2−4 and extensive
biochemical and biophysical research,6−15 a distinct under-
standing of the molecular mechanism by which oxygen
reduction is coupled to proton pumping is still elusive, while
the manner by which turnover is controlled by the PMF
remains relatively unexplored. HCOs, including cytochrome
bo3, have been observed to reduce activity in the presence of
high PMF.16,17 A “slip” in their pumping stoichiometry
(decrease in the proton-to-electron ratio) has been observed
in many HCO studies16 and also for other transport systems.18
The implications of these alterations in stoichiometry have
been previously discussed for HCOs and for pumping ATPases
and transporters in healthy and disease states.5,18−21 Slips in
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substrate transport have been proposed to act as a “safety valve”
through which excess driving force can be dissipated18 and it is
proposed to be a mechanism by which HCOs can optimize the
condition for ATP synthesis.16 Maintaining such balance is
important since high PMF and a highly reduced electron-
transport chain (high ratios in ubiquinol/ubiquinone and
NADH/NAD+) have been linked to increased production of
reactive oxygen species (ROS) in mitochondria,16,22 which has
been implicated in aging, cancer, and other diseases.23,24
Current understanding of the pumping mechanism of HCOs
primarily relies on ensemble studies averaging the behavior of
multiple pumps.25−28 While providing a great wealth of
information, these studies average out rare events during
continuous turnover, masking the dynamic heterogeneity of
HCOs and eﬀectively preventing detection of leak states.
Single-molecule studies on the other hand oﬀer the exquisite
ability to directly observe the temporal ﬂuctuations of
individual enzymes and their role in regulation of their
activities.29,30 Single-enzyme studies were pioneered for ion
channel current recordings and, more recently, single-enzyme
studies on transporters have visualized the structural dynamics
of transmembrane helices.31 However, neither method can
directly report on proton pumping during continuous turnover.
Here, we have developed a novel platform that can directly
observe the proton transfer of single cytochrome bo3 enzymes
for prolonged periods (up to 100 s; Figure 1a). Our studies
reveal that cytochrome bo3, a representative HCO enters a rare,
long-lifetime “leak state” during which protons rapidly leak or
are transported back along the transmembrane electrochemical
potential and ΔpH. Our ﬁndings support a view in which one
of the underlying causes of the previously observed reductions
in the H+/e− stoichiometry is a leak state, which provides new
insights into the molecular mechanism of proton pumping in
HCOs and its regulation by excessive ΔpH. The novel method
described in this study also adds to the ever expanding library
of techniques to study single molecules on surfaces by
combining optical and electrochemical methods.32
■ RESULTS AND DISCUSSION
This study was carried out on cytochrome bo3, an ubiquinol
oxidase from E. coli. A key diﬀerence between bo3 and
cytochrome c oxidases such as Complex IV is their electron
donor, which are ubiquinol and cytochrome c, respectively.
This allowed us to design a combined electrochemical-
microscopic experimental setup for single-enzyme analysis as
schematically shown in Figure 1. In this setup, which is
described in detail in the Materials and Methods, proteolipo-
somes containing cytochrome bo3 are sparsely adsorbed on a
transparent ultrasmooth thin gold electrode within an electro-
chemical cell. The gold is modiﬁed with a self-assembled
monolayer of 6-mercapto-hexanol, which renders it hydrophilic
and allows immobilization of the proteoliposomes, that retain
the pH sensitive ﬂuorophore. To approach single-enzyme
conditions, the proteoliposomes are made using a very low
protein-to-lipid ratio. Because of the low protein-to-lipid ratio,
most of the liposomes in the experiments do not contain a
protein and we will adopt the term “(proteo)liposomes” in the
remainder of this text to reﬂect this. Image analyses procedures
are used to exclude (proteo)liposomes that are close together
by picking circular and separated bright spots with a typical size
that is consistent with single vesicles (see Materials and
Methods). Nonetheless, this analysis will not be able to detect if
two (proteo)liposomes are less than 200 nm apart. As
described in the Supporting Information, simulations based
on assumption that vesicles randomly adsorb on the surface
suggest that this will occur in only 0.3 ± 0.2% of ﬂuorescent
spots. Because most (proteo)liposomes do not contain an
enzyme, the probability that two proteoliposomes with an
enzyme coincide in a single ﬂuorescent spot is much lower.
The (proteo)liposomes also contain ubiquinone that is
electrochemically reduced to ubiquinol, thereby activating the
oxygen reducing activity of cytochrome bo3. The (proteo)-
liposomes are loaded with a pH-sensitive ﬂuorescent dye
(hydroxypyrene-1, 3, 6-trisulfonic acid trisodium salt (HPTS))
and the electrochemical cell is placed in an epi-ﬂuorescent
microscope that monitors the ﬂuorescence which, with the use
of separately determined calibration data and the measured
vesicle sizes, is converted to intravesicular pH and the number
of transported protons in individual (proteo)liposomes (see
Supporting Information for the calibration procedure).
Figure 2 shows a collection of typical (proteo)liposome time
traces, where the intravesicular pH changes (see Figure S1) are
used to calculate the cumulative number of transported
protons. Because of the low protein-to-lipid ratio used, the
majority of the observed (proteo)liposomes were plain
liposomes and did not portray any change in pH upon
reducing the ubiquinone pool electrochemically (Figure 2f).
During the time window the ubiquinone pool was electro-
chemically reduced (dashed lines in Figure 2), about 15% of the
observed (proteo)liposomes displayed signiﬁcant pH changes
(0.1 < ΔpH < 1 and in rare cases up to about 2 units). Indeed,
the average number of cytochrome bo3 complexes per
(proteo)liposome is calculated to be 0.16 using the average
protein-to-lipid ratio and the average (proteo)liposome size
(see Materials and Methods for details). Assuming Poissonian
dilution of proteins/liposome we would then expect 15% of
liposomes to contain one active protein and ∼1% of liposomes
Figure 1. Schematic diagram of the experimental method. Proton
uptake/release activity of reconstituted cytochrome bo3 is controlled
by reducing ubiquinone electrochemically (a). The change in
intravesicular pH is determined via an encapsulated pH-sensitive
ﬂuorescent dye, 8-Hydroxypyrene-1,3,6-trisulfonic acid (HPTS) (a). A
color-inverted ﬂuorescent image (b) and the ﬁtting of the ﬂuorescence
of the circled proteoliposome by a Gaussian function (c) (the grid is
raw data, and the colored surface is the ﬁtting result) are shown. The
sample image in (b) shows a small area of the whole image which
typically contains hundreds of (proteo)liposomes.
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to have more than one protein. This calculation is concurrent
with our hypothesis that most (proteo)liposomes displaying pH
changes are due to proton uptake/release by single enzymes,
which however could not be conﬁrmed via direct experimental
measurement. Deviations from the calculated average number
or proteins/liposome are expected because of the polydispersity
in (proteo)liposome diameter (71 nm with a full width at half
maximum (fwhm) of 45 nm, Figure S8) and hence surface area.
Additional deviations at the level of single particles could be
present due to the heterogeneous distribution of proteins33
and/or lipids.34
The pH values were observed to both increase and decrease
(Figure 2a and 2b, respectively; hereafter these proteolipo-
somes will be described as “active” liposomes or vesicles),
indicating cytochrome bo3 was present in both orientations in
the proteoliposomes. About 76% of active vesicles show a pH
increase consistent with a “right-side out” orientation. The
single-enzyme traces reveal a distribution in turnover rates
(Figure 3), while in more than 10% of cases, cytochrome bo3
was observed to abruptly halt proton uptake/release (Figure
2e). Such dynamic heterogeneity and “stalling” of activity was
observed for enzymes in both orientations and is a feature
typically observed for (single) enzymes.29 Importantly,
however, a signiﬁcant fraction of our single enzyme traces
(7.2 ± 1.5%) also show abrupt turns in pH changes, rapidly
destroying formed ΔpH even when the potential was still
applied to reduce the ubiquinone pool. Such events were
observed for cytochrome bo3 in both orientations, as shown in
Figure 2c and d.
In order to quantitatively analyze the heterogeneous activity
of the enzyme and resolve the distinct phases in the time traces
(e.g., Figure 2c−e) without human bias, an automatic trace
analysis was coded and its results are visualized by the red lines
in Figure 2 (see Materials and Methods for details). To
reproduce the ﬁndings, they were recorded in two separate
laboratories, ﬁrst in Copenhagen and then in Leeds. Two
diﬀerent methods varying in experimental setup, pH-dependent
ﬂuorescent probe (HPTS vs SNARF-1), and materials were
used, which further support their validity (see the Independent
Veriﬁcation section in the Supporting Information). Two
diﬀerent image and data analysis procedures were also tested
and compared, and both methods conﬁrmed the conclusions
presented below. The data analysis procedure resolves phases/
events which are statistically distinctive (proton translocation,
proton leakage and the stalling phase) within the time-traces
and yields measurements such as the average proton trans-
location rate for each event, the duration of the event, and the
ΔpH at the onset of each event.
The proton translocation rates correspond to an ensemble
average of 73 ± 2.2 protons s−1 (Figure 3), which is less than
the published activity of 520 electrons s−1 in reference35 and
850 electrons s−1 in reference.17 We ascribe this diﬀerence to
various reasons: (a) only about half of the maximum activity of
cytochrome bo3 is reached at the electrochemical potential used
to activate cytochrome bo3 in the single-enzyme experiments
(−0.2 V vs standard hydrogen electrode (SHE), Figure 4) and
(b) Vmax condition cannot be reached using ubiquinol-10 as the
electron donor. Ubiquinol-10 is nearly identical to the native
electron donor in E. coli (ubiquinol-8). However, previously
reported values were measured using substrate analogues
(decyl-ubiquinol35 or ubiquinol-117) under saturation con-
ditions, while here ubiquinol-10 was added to the (proteo)-
liposomes under nonsaturating conditions (1% w/w ubiquinol-
10/lipid). Saturation of ubiquinol-10 in the membrane is not
possible due a disrupting eﬀect of high ubiquinol-10
concentrations and a previously reported substrate inhibition
eﬀect.36
Analysis shows that 7.2 ± 1.5% of the proton-transporting
proteoliposomes abruptly switch to seemingly passive leaking
within the potential window. The reproducibility and statistical
robustness of our analysis is veriﬁed by 4 independent series of
experiments with cytochrome bo3 from two diﬀerent over-
Figure 2. Examples of time traces of (proteo)liposomes. Example
traces are given for proteoliposomes where protons are pumped
throughout the application of the electrochemical potential (a,b),
proton leakage (c,d), proton uptake/release cessation without leakage
(e). An example trace of a liposome without cytochrome bo3 is also
shown (f). Red lines in the example traces (a−f) are ﬁts to the data
(gray) as explained in the text. Proton uptake/release activity was
initiated by applying an electrochemical potential between time points
indicated by the vertical dashed lines.
Figure 3. Distribution of proton translocation rates for (top) wild-type
cytochrome bo3 (middle) E286C cytochrome bo3 and (bottom) wild-
type cytochrome bo3 in the presence of valinomycin. Cytochrome bo3
was orientated both ways in the single-enzyme proteoliposomes and
relative frequencies are separated for “proton uptake” (positive rates)
and “proton release” (negative rates). The rates are determined from
the slope of the analyzed data for which examples are shown in Figure
2. The error bars represent the standard error of the mean.
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expressing strains, which show maximum and minimum leak
probabilities ranging from 2.9 to 9.5%. Statistically, these leak
events are inconsistent with multiple enzymes per active vesicle,
as it would require two oppositely orientated cytochrome bo3
complexes to behave in certain patterns, e.g., one enzyme
stopping and the other starting at about the same time or the
slower enzyme halting activity ﬁrst. To conﬁrm that leak events
are obtained from proteoliposomes containing single enzymes,
the experiments were repeated with an average protein-to-lipid
ratio 1 order of magnitude lower, where the stochastic
probability of having two oppositely oriented protein
complexes is 2 orders of magnitude lower (<0.1%). As
expected, the number of (proteo)liposomes displaying pH
changes was signiﬁcantly reduced (2.5% ± 0.33%), but the
abrupt switch was still observed for 3.2% ± 0.65% of the active
vesicles (4 independent experiments with leak state percentages
between 1.9 and 4.5%). We propose that these data further
conﬁrm that the leak activity is due to single proteoliposomes
with single enzymes.
Although it is known that membrane pores can randomly
form in the presence of ΔpH, pores are transient, submilli-
second events.37,38 The observed lifetime of the leaking events
(>10 s) is thus inconsistent with spontaneous pore formation in
the lipid membrane of the vesicles. Furthermore, the proton
permeability of the reconstituted proteoliposomes was
independently measured by applying a ΔpH to the
reconstituted proteoliposomes and empty liposomes under
nonturnover conditions. In both cases the recorded “back-
ground” proton leaking rate is signiﬁcantly lower than the
observed leak states of cytochrome bo3 (Figure S2), conﬁrming
that background proton permeability is negligible under our
conditions. Furthermore, the fact that we observe similar
background proton permeability for proteoliposomes recon-
stituted with cytochrome bo3 and empty liposomes veriﬁes that
leaking is not an artifact of the reconstitution method. Taken
together the abrupt changes in proton transport direction are
most likely due to single enzyme-related proton leakage into or
out of the proteoliposomes.
A simple explanation for the observed leak events and stalling
is that they are due to irreversible inactivation or damage to
cytochrome bo3. Because less than 10% of the proteoliposomes
enter the leak state and because the time-span of the
experiments is limited (up to 100 s of active turnover) it is
not possible to directly observe the rare recovery events. In
addition, there is also the possibility, albeit low, of
proteoliposomes containing two enzymes (or two proteolip-
somes are less than 200 nm apart) and thus registering “false”
recovery events. We therefore analyzed the relative number of
proteoliposomes in consecutive movies on the same electrode
(Figure S3). The percentage of the proteoliposomes containing
cytochrome bo3 that actively take up/release protons does not
decrease when movies were taken sequentially. The movies
were taken from diﬀerent areas on the same electrode, but lipid
vesicles that were not being ﬂuorescently imaged are still
subjected to the same electrical potential applied to the gold
electrode which would start the enzyme turnover. Therefore, if
cytochrome bo3 could not revert back to normal proton
translocation after entering the leak state or the stalling phase,
the percentage of active vesicles would have shown a
continuous decline. The lack of such downward trend indicates
that both the leak state and the stalling phase are reversible.
It is generally accepted that back-ﬂow of protons during
turnover of HCOs is prevented by a gate in the D-channel.28,39
We hypothesized that the long-lived leak events are caused by a
conformational change causing the gate to “open” allowing
protons to freely ﬂow back. Glutamic acid 286 (E242 in bovine
heart Complex IV) is highly conserved in Type A1 HCOs and
lies at the end of the D-channel.1 It has been suggested that
E286 is an integral part of the gating mechanism28,39 and to test
this hypothesis, the same measurement and analysis was applied
using an E286C mutant.
In E286C cytochrome bo3, proton translocation through the
D-channel is blocked and protons are prevented from being
pumped across the membrane.39 It is worth noting that besides
the pumped protons, redox reactions in cytochrome bo3 result
in a further net translocation of four “chemical protons” across
the membrane: the reduction of every dioxygen molecule draws
four protons from the cytoplasmic side and another four
protons are released into the periplasm after the oxidation of
two ubiquinols.2 The E286C mutant is catalytically active
(Figure 3 and 4) and thus able to generate a ΔpH via the net
translocation of “chemical protons”. We note here that
ubiquinone is also protonated when electrochemically reduced
at the electrode. However, since electrons cannot transfer
across the lipid bilayer, this process takes up protons from
solution only (i.e., from outside the vesicles) and should
therefore not inﬂuence the intravesicular pH.
The orientation of E286C cytochrome bo3 is similar to wild
type (WT): 66% of proteoliposomes with E286C cytochrome
bo3 take up protons from the inside of the lipid vesicle
(alkalinization), compared to 76% of WT. The oxygen-reducing
activity of E286C cytochrome bo3 as measured by the
electrochemical current (Figure 4) is about 15−20% of that
of wild-type cytochrome bo3, depending on the potential at
which the comparison is made. The lower proton-transporting
activity of E286C cytochrome (22% of that of WT, Figure 3) is
consistent with the lower oxygen reducing activity, although
higher than expected considering the fact that E286C
cytochrome bo3 can only release/uptake one proton per
electron rather than two for wild-type cytochrome bo3. This
we attribute to the data analysis and noise levels, as very low
proton uptake/release rates are hard to detect.
The single-enzyme experiments show that the relative
frequency by which E286C enters the leak state is signiﬁcantly
Figure 4. Cyclic voltammograms (CVs) of absorbed proteoliposomes
of WT and E286C cytochrome bo3. Electrode preparation and
modiﬁcation are identical to the single-enzyme experiments except
that 150 nm gold was used, proteoliposomes were reconstituted with a
higher protein-to-lipid ratio (1% w/w) and full layer of proteolipo-
somes were immobilized on the electrodes by incubating the electrode
with 0.5 mg/mL proteoliposomes for 30 min. CVs (2 mV/s) were
measured under ambient, aerobic conditions at 20 °C. The onset of
ubiquinol-10 reduction in the proteoliposomes starts at about −0.05 V
vs SHE. CVs of proteoliposomes before and after addition of 10 μM
valinomycin are shown. A CV of the electrode surface prior to
immobilization of proteoliposomes (blank) is also depicted.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.5b08798
J. Am. Chem. Soc. 2015, 137, 16055−16063
16058
reduced to 0.6% (0.5% and 1% in two independent data sets
each containing eight and 20 movies, respectively), compared
to 7.2% for wild-type cytochrome bo3. Besides the signiﬁcantly
reduced percentage of leak events observed for E286C
cytochrome bo3, the leaking rates are also signiﬁcantly lower
for E286C (25.5 ± 4.1 H+/s vs 102.3 ± 11.2 H+/s for the wild-
type, Figure 5). We propose that these results further
substantiate that the leak events observed from wild-type
cytochrome bo3 are caused by a leak state of the proton pump
and not by oppositely orientated enzymes or pore formation in
the lipid membrane. Although the results from the E286C
mutant conﬁrm that protons leak through the protein, they do
not unambiguously show that protons ﬂow via the D-pathway
and more work is needed to identify the leak pathway. Because
this mutant is less active than WT, the E286C mutation could
allosterically reduce the probability that a leak state is formed.
Indeed, on average, the lifetime of proton uptake/release in
E286C cytochrome is about 25% longer than WT (Figure S4),
but as lifetimes longer than 100s were capped because of the
technical limitations on for how long an experiment can
continue, this should be considered a lower limit. Therefore,
there is an indication that the E286C mutant may have a longer
lifetime for proton uptake/release. Related to this, the “stalling”
behavior was observed in only 4% of the active vesicles.
We next examined whether the existence of the leak state
may have a potential regulatory role. A possible cause that
triggers cytochrome bo3 into the leak state is a thermodynami-
cally limiting PMF, i.e., high ΔpH and/or high membrane
potential. Figure 5 shows that the leak states may be initiated at
all ΔpH (horizontal axis in the heat map), and many leaking
events started at low ΔpH. However, the relative frequency
shown in Figure 5 is the frequency observed for the total
population of active vesicles, which does not take into account
that the majority of active vesicles never reached a high ΔpH or
the fact that high ΔpH are only obtained for a relatively short
time periods (Figure 6a). Figure 6d shows that by normalizing
the frequency of the leak state against the relative occurrence of
a ΔpH, the leak states is more likely to be initiated at higher
ΔpH. The result of Kendall tau rank correlation test shows that
the relative frequency of entering a leak state from all repeated
experiments is indeed positively correlated to the ΔpH (p <
0.01, τ = 1). The same analysis shows that the probability of
entering a stalling phase is similarly correlated to the ΔpH
(Figure 6e). Thus, our data suggest that cytochrome bo3 might
have evolved two mechanisms to control excessive ΔpH and
either halts proton translocation or enters a proton leak state,
dissipating the formed PMF. As mentioned above, the E286C
mutant exhibits a longer lifetime of proton translocation. As the
relative frequencies of the leak and stalling states of cytochrome
bo3 are dependent on the ΔpH (Figure 6), the longer lifetime
could thus indirectly be due to the slower proton uptake/
release activity of E286C cytochrome bo3 compared to WT.
Figure 5. The relative frequency (in percentage) of entering the leak state during turnover in relation to the leaking rate and the ΔpH formed prior
to the start of the leaking events. These ﬁgures are two-dimensional histograms generated in the same way as the conventional one-dimensional
histogram (the color of the pixels is equivalent to the height of the bars in histogram bar chart). The sum of the relative frequency values in each heat
map equals to the total relative frequency of proteoliposomes entering the leak state in the corresponding experiment. The ΔpH is the intravesicular
pH minus the pH of the bulk solution (set constant at 7.4).
Figure 6. The relative frequency (in percentage) of cytochrome bo3
entering the leak state or stalling phase within the time resolution of
the experiment as a function of ΔpH. (a) the average frequencies that
a ΔpH is encountered during a 2.6 s period of the time trace (i.e., the
time resolution); (b,c) the distribution of the ΔpH formed just before
entering the leak state or stalling phase, respectively; (d,e): the relative
frequency of cytochrome bo3 entering the leak state or stalling phase,
respectively, as a function of ΔpH, which was calculated by dividing
the frequencies in (b) and (c) by those in (a) for each independent
experiment; the error bars show the standard error of the mean from 4
independent experiments. The negative ΔpH and negative proton
release rates (acidiﬁcation) have been converted to the absolute
(positive) values. The ΔpH is the intravesicular pH minus the pH of
the bulk solution (constant at 7.4).
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We next examined the role of transmembrane potential on
triggering the leak state. Proteoliposomes are ideally suited for
this as it has long been recognized that due to small volume in
proteoliposomes, proton transport alone can build up a
membrane potential.40 To probe the inﬂuence of the
membrane potential, the same experiment and analysis were
performed on the wild-type cytochrome bo3 in the presence of a
potassium ion carrier, valinomycin, which will signiﬁcantly
reduce or eliminate the membrane potential, while retaining the
ΔpH. By comparing the results of cytochrome bo3 alone and
cytochrome bo3 with valinomycin in Figure 5, it is clear that
valinomycin lowers the leaking rate (see also Figure S5). On
average, the presence of valinomycin reduced the leaking rate
by 60%, conﬁrming that a signiﬁcant membrane potential is
present and thus that proton transfer by cytochrome bo3
contributes to the formation of both terms of the PMF in
our single-enzyme experiments (ΔpH and membrane poten-
tial). The relative frequency, however, with which cytochrome
bo3 enters the leak state is not reduced by the presence or
absence of valinomycin. As without valinomycin, the relative
frequency of entering the leak state is correlated to the ΔpH in
the presence of valinomycin (Figure S6, see SI for a further
discussion on the eﬀect of valinomycin on the proton transport
activity of cytochrome bo3). These observations suggest that
entering the leak state may be primarily triggered by the ΔpH,
though we cannot fully exclude that a larger membrane
potential can also trigger a leak state. In contrast, the rate of the
proton back ﬂow once a leak state is obtained seems to be
driven by both elements of the PMF (Figure 5) suggesting that
the leak state is due to a protein conformation that allows
protons to freely ﬂow backward, in a fashion similar to a proton
channel.
■ CONCLUSION
We conclude that a long-lifetime leak state exists in cytochrome
bo3 during continuous enzyme turnover, which allows the back
ﬂow of protons. The leak state and the stalling in enzyme
activity may act as a safety fuse that is triggered by excessive
ΔpH during respiration in E. coli. Previous study shows that
ROS production in mitochondria may be much more sensitive
to ΔpH than to membrane potential.41 Although seemingly
ineﬃcient in terms of energy conservation, proton leakage in
small subpopulations of HCOs in a living organism might help
to alleviate respiratory pressure and factors related to ROS
production. The existence of the long-lifetime proton leak state
and the stalling phase may provide an unprecedented insight
into the proton pumping mechanism and its regulation in
HCOs. Deciphering the precise role of proton leakage of
proton transporters as well as its dependence on regulatory
inputs and point mutations by assays like these will pave the
way for controlling transport related diseased states.
■ MATERIALS AND METHODS
Protein Puriﬁcation and Reconstitution. All chemicals were
purchased from Sigma-Aldrich unless otherwise stated. Wild-type and
E286C cytochrome bo3 were puriﬁed from Escherichia coli C43 strains
with the bo3 gene knocked out from chromosome, where proteins
were expressed from pET plasmids containing the corresponding gene
sequences.39 Wild-type cytochrome bo3 was also puriﬁed from
GO105/pJRhisA42 for comparison. Proteins were puriﬁed similarly
as previously reported.35 Cytochrome bo3 concentration was
determined by its Soret band at 409 nm (ε = 188 mM−1 cm−1).
Protein was reconstituted following a method published previously,17
except 20 mM MOPS buﬀer was used instead of HEPES. Before Bio-
Beads were added, the pH sensitive dye, 8-hydroxypyrene-1,3,6-
trisulfonic acid trisodium salt (HPTS), was added to a ﬁnal
concentration of 5 mM. The lipid mixture used for the reconstitution
was E. coli polar lipid extract (Avanti Polar Lipids, Inc., Alabama,
U.S.A.) mixed with the following: 1% (w/w) ubiquinone-10 and 0.4%
(w/w) ATTO-633 labeled DOPE (ATTO-TEC GmbH, Germany).
The protein-to-lipid weight percentage added for the reconstitution is
0.2%. Insoluble materials, possibly denatured protein, were removed
by low-speed centrifugation at 17 000 RCF for 5 min at the end of the
reconstitution. Standard BCA and Schaﬀner & Weissmann assays were
both used to quantify the amount of protein that is actually
reconstituted into lipid vesicles, and the loss of lipid during
reconstitution was also quantiﬁed by the absorption of the
ATTO633 labeled lipid. The results show that the ﬁnal protein to
dry lipid ratio (w/w) is 0.073 ± 0.004%. To estimate the average
number of bo3 complexes in a single vesicle, the following values were
used: the protein/lipid weight ratio (0.073%), the size of the vesicle
(70 nm), the thickness of the lipid bilayer (5 nm), the average surface
area of the lipid headgroup (65 Å2), the molecular weight of the
protein (144 kDa), and the average molecular weight of the lipid
(760). Under the assumption that a lipid vesicle is a double-layered
sphere with an outer diameter of 70 nm and an inner diameter of 70 −
2 × 5 = 60 nm, one can calculate the number of lipid molecules in a
vesicle. Using the protein/lipid ratio, one can further calculate, on
average, how many protein complexes are present in a vesicle.
Dynamic light scattering data showed that (proteo)liposomes in this
study were highly monodispersed and are about 70 nm in diameter
(Figure S7).
Electrochemistry-Microscopy Measurement. The experimen-
tal setup was reﬁned from a method reported previously42 to enable
single-molecule measurements. Template-stripped gold electrodes
with highly smooth transparent gold layers on glass substrates were
functionalized with a 6-mercapto-1-hexanol (6-MH) self-assembled
monolayer (SAM). They were prepared by the following procedure:
30-nanometer gold layers were thermally evaporated on polished
silicon wafers (IDB Technologies Ltd., U.K.) with an Edwards Auto
306 evaporator (Edwards, U.K.) at a pressure ≤2 × 10−6 millibar.
Standard-thickness glass coverslips were then glued to the gold layer
with a low-ﬂuorescence epoxy glue (301−2FL, Epoxy Technology,
Inc., Massachusetts, U.S.A.). After the glue cured, coverslips were
carefully removed from the silicon wafers, during which the gold layer
was stripped oﬀ the wafers, retaining the high smoothness of the
silicon wafer template. The SAM layer was made by incubating the
gold electrodes in 1 mM 6-MH solution in water overnight at 20 °C.
The gold electrode is a part of a custom-built electrochemical cell that
can be used with an inverted epi-ﬂuorescence microscope (Eclipse Ti−
U, Nikon Instruments, U.K.). After assembling the electrochemical
cell, (proteo)liposomes were sparsely absorbed to the gold electrode
by incubating the gold surface with a diluted suspension (2 μg/mL
lipid) for 30 min at 20 °C followed by a thorough washing step to
remove unbound (proteo)liposomes and nonencapsulated HPTS dye.
We note that the experiments are conducted under ambient conditions
and in ensemble experiments we have previously shown that this
ensures that cytochrome bo3 remains saturated with oxygen
throughout the experiment.36
Images and image series were recorded using a 60× oil immersion
objective (N.A. = 1.40, Nikon Instruments, U.K.), and an Andor Zyla
5.5 sCMOS Camera system (Andor Technology Ltd., U.K.).
Fluorescence ﬁlters used in this study were from Chroma Technology
Corporation (Vermont, U.S.A.): (1) D470/20X, excitation of one of
the HPTS channels; (2) D410/30X, for excitation in another HPTS
channel; (3) HQ535/48M, emission of both HPTS channels; (4)
500dcxr, dichroic mirror for both HPTS channels; (5) HQ620/60X,
excitation of the ATTO633 ﬂuorescence; (6) HQ700/75M, emission
of the ATTO633 ﬂuorescence; (7) Q660lp, dichroic mirror for
ATTO633 ﬂuorescence. The original images are 2560-by-2160 pixel/
179-by-151 μm. The magniﬁcation is 60 (objective) × 1.5 (relay lens)
= 90 times. The exposure time is 1 s for each channel, and the frame
rate is 2.6 s−1, including 0.6 s for rotating the ﬁlter cubes. A typical
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image series contains about 500−1000 lipid vesicles. Examples of the
full-scale images are shown in Figure S9.
A potentiostat (Chi604c, CH Instruments, Inc., Texas, U.S.A.) was
used to control the potential between the working electrode (the gold
electrode with lipid vesicles) and a Ag/AgCl/sat. KCl (199 mV vs
Standard Hydrogen Electrode, SHE) reference electrode (Radiometer
Analytical SAS, France). A platinum wire was used as the counter
electrode. When the potential is applied to the gold electrode, the
ubiquinone pool in the vesicles’ lipid bilayer is electrochemically
reduced and after diﬀusion through the vesicle, donates electrons to
cytochrome bo3, initiating oxygen reduction and proton uptake/
release. Recording of image series was initiated while the potentiostat
was switched oﬀ. After a given amount of time (typically 30 or 100 s)
the potentiostat cell was switched on to maintain a constant potential
of −0.2 V vs SHE for 100 s. This potential is optimal based on
previous results.42 The potentiostat was then switched oﬀ again but
the image recording would continue for certain amount of time
(typically 100 or 150 s). When the electrochemical potential is
terminated, the proton uptake/release activity is found to halt within
the time resolution of this study and, thus, the enzyme activity is
tightly controlled by the potentiostat. There is a minimum of 15 min
waiting period between each recording to allow the ΔpH and
membrane potential to dissipate, and the ﬁelds of view of diﬀerent
recording sessions do not overlap. Typically 5 recordings were done
on each gold electrode due to the limit of their available surface area.
Each experimental system (wild-type bo3, E286C mutant and
valinomycin) contains data collected from diﬀerent batches of
preparation and each batch contains recordings from multiple
electrodes. The numbers of independent lipid vesicles analyzed in
each of the three experimental system described in the main text were
on the scale of 19 000−30 000, of which about 3000 vesicles exhibit
proton uptake/release.
Experiments with valinomycin added were done with the following
steps. Cytochrome bo3 was reconstituted using the same protocol as
above and valinomycin was added to a ﬁnal concentration of 10 μM
with the lipid concentration adjusted to 4.4 mg/mL. The approximate
molar ratio of valinomycin to lipid is 1.8 × 10−3. The valinomycin was
incubated with (proteo)liposomes for 15 min before further dilution
to 2 μg/mL lipid and absorption onto the gold electrode, as above.
However, after unbound (proteo)liposomes and nonencapsulated
HPTS dye were removed by washing, a new valinomycin/liposome
mixture (10 μM and 4.4 mg/mL, respectively; liposomes were without
HPTS or cytochrome bo3) was added to the solution to replenish the
loss of valinomycin during the incubation and washing and keep the
ratio of lipid and valinomycin relatively constant. Since the liposomes
added here do not contain any ﬂuorescent dye or ﬂuorescently labeled
lipid, they do not interfere with the image recording.
Data Analysis. Before the start of an experiment a single
ﬂuorescence image was taken to obtain the ATTO-633 ﬂuorescence
intensity of individual (proteo)liposomes containing 0.4% (w/w)
ATTO-633 labeled DOPE. This image was used to calculate the
diameter of the (proteo)liposomes with a method similar to that
previously published.43 Dynamic light scattering (Zetasizer Nano ZS,
Malvern Instruments Ltd., U.K.) data were used to establish a
calibration curve between ATTO-633 ﬂuorescence and the diameter of
the vesicles. Figure S8 shows that the conversion from ATTO
ﬂuorescence to diameter does not distort the size distribution of the
lipid vesicles.
Fluorescent image time-traces were recorded alternating between
the excitation ﬁlters for HPTS ﬂuorescence. Image series were
registered and corrected for drifting using ImageJ StackReg plug-in.44
All subsequent analysis was performed in MATLAB R2012a
(MathWorks, Massachusetts, U.S.A.) using user-written code. Lipid
vesicles were identiﬁed on each frame of the image series and a two-
dimensional Gaussian function was used to ﬁt each vesicle HPTS
ﬂuorescence image. Using user-written code, comprehensive and
automatic quality checking was carried out for each ﬁtting on every
frame to eliminate conglomerates, close-by vesicles, vesicle desorption
during recording and vesicles on the edge of images. The code was
written assuming the following: (1) single vesicles will appear as
circular bright spots on the image; (2) because the bright spots are
sparsely distributed on the images, the majority of them are single
vesicles; (3) a cluster of vesicles will appear either noncircular or much
larger. An automated image analysis was performed with MATLAB to
remove noncircular spots or spots larger than expected for single
vesicles. As the vesicles are sparsely adsorbed, an accurate value for the
background intensity can be determined. Vesicles are then identiﬁed
by the MATLAB code by ﬁnding pixels above certain threshold
intensity. Then a 12-by-12 (pixel) local image (∼0.84 × 0.84 μm)
around the bright pixel was ﬁtted to a 2-dimension Gaussian function.
The ﬁtting returns 4 parameters (baseline, amplitude, X-spread and Y-
spread) and the ﬁtting error at each pixel. These results are used to
reject bright spots with the following characteristics: (1) ﬁtting error
above 20% (comparing to the original intensity data) at any pixel; (2)
ﬁtting error above 10% overall (in the 12-by-12 area); (3) circularity
below 0.8; (4) fwhm is below 35 nm (= 0.5 pixel) or above 175 nm (=
2.5 pixel); (5) amplitude above background is below 1000 AU
(arbitrary unit, background is about 3000 AU with a standard deviation
about 150 AU); (6) baseline above 10 000 AU (this is usually
concurrent with a large fwhm); (7) too close to the edge of image (6
pixel); (8) having another bright spot within 700 nm; (9) the ﬁtted
center is more than 2 pixel away from the brightest pixel (this is
usually concurrent with a large fwhm); (10) in addition, after all
images in a movie are ﬁtted, if any of the above criteria is not satisﬁed
in more than 30% of the frames of the movie, the vesicle is rejected
entirely. The above criteria were chosen because they result in picking
circular and separated bright spots with a typical size that is consistent
with single vesicles.
The ratio of the ﬂuorescence intensity of HPTS with the two
excitation ﬁlters was used to calculate the pH inside the individual
(proteo)liposome at the time of measurement. A calibration curve was
established to convert the ratiometric HPTS data to pH. This
calibration was done by measuring single (proteo)liposomes’ HPTS
ﬂuorescence in the same procedure as described above at diﬀerent pH
values. Diﬀerent pH points were achieved by changing the bulk
solution’s pH and adding 100 ng/mL nigericin and 100 ng/mL
gramicidin to equilibrate the intravesicular pH with the outside.
Because of the presence of gramicidin and nigericin, the intravesicular
pH equals the pH of the bulk solution, and the bulk solution pH was
measured. Therefore, the calibration procedure can eﬀectively control
the intravesicular pH. The ﬂuorescence images for pH-ﬂuorescence
calibration were taken using the same procedure as the movies. The
ﬂuorescence data and pH were ﬁtted to a Henderson−Hasselbalch
equation and the parameters obtained were used to convert HPTS
ratiometric ﬂuorescence to intravesicular pH during turnover of
cytochrome bo3. The ﬁtting results are given in Supporting
Information (Figure S10 and Table S1). The number of protons
taken/released was then calculated based on the diameter of lipid
vesicle, the pH change and the buﬀering eﬀect of MOPS buﬀer, HPTS
and the lipids. We note that the obtained time traces, such as shown in
Figure 2, are qualitatively identical irrespective of whether pH or
cumulative number of transported protons is plotted (compare Figure
2 with Figure S1). To calculate the cumulative number of transported
protons, the concentrations of MOPS buﬀer and HPTS encapsulated
within the lipid vesicles were assumed to be the same as the bulk
solution. The buﬀering capacity of lipids was determined empirically
by a titration beforehand while the lipid surface area of single vesicles
was calculated from the vesicle size. The buﬀering capacity of MOPS
and HPTS are calculated using the Henderson−Hasselbalch equation.
Each (proteo)liposome’s change in the pH and the number of taken/
released protons were then calculated and stored.
The sections of time traces recorded after the applied potential was
switched oﬀ were ﬁtted with an exponential decay function. The
sections of the time traces within the potential window were then
analyzed using user-written code to detect the proton taken up/
released and leaking events. This automatic analysis is based on the
hypothesis that a correlation between the pH/number-of proton taken
up/released and time indicates either an active proton uptake/release
or leaking event. It consists of ﬁtting the data to models of one or
multiple joint lines and, for each line (segment), the calculation of
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Kendall tau rank correlation coeﬃcient. In order to prevent overﬁtting
of the trace by multiple lines, the ﬁtting would start with a single linear
regression (a single segment). If the standard deviation of the residual
was less than 110% of the standard deviation of the trace, the
procedure was stopped and the Kendall tau value determined. The
standard deviation of the trace is independently determined using the
data prior to the application of the potential. It is assumed that the
intravesicular pH before the applying a potential is constant and that
the noise level is consistent during the entire trace. If the standard
deviation of the residual of the segment is higher than 110%, the data
is ﬁtted to two joined segments (i.e., the start of the second segment
joins with the end of the ﬁrst segment), where an iterative process is
used to determine, based on the best ﬁt, at which time-point the two
segments are connected. If any of the segments still has a residue with
a standard deviation above 110%, this process is continued.
To further check if the use of multiple segments is statistically
justiﬁed, adjusted R2 values are determined for ﬁts using one, two or
more segments, and the ﬁt with the highest adjusted R2 value is used.
Adjusted R2 takes into account the degrees of freedom in relation to
the number of ﬁtted parameters. P-values were calculated as part of the
Kendall test on the resolved sections from the model ﬁtting and only
the sections of time traces with P-values below the threshold of 0.05
(95% conﬁdence level) were accepted as proton uptake/release or
leaking events. Proton uptake/release or leaking rates are taken from
the slopes of the segments. The data was analyzed with higher and
lower conﬁdence levels and was found to be qualitatively identical.
Finally, a leak event is deﬁned as a change in the sign of a slope for two
adjoining segments, where it is assumed that the ﬁrst segment is due to
active proton uptake/release.
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